LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
DIVERSE VOICES
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
15 hours ago
Coping with adversity when living with a rare disease bit.ly/3PUz6c8. Please read now at PatientWorthy.com. ... See MoreSee Less
Coping with adversity when living with a rare disease – Patient Worthy
Adversity comes in all shapes and sizes and how we deal with it differs from person to person. I have faced great adversity at different times in my life, some of which I handled well and some not so ...
View Comments
- likes 0
- Shares: 0
- Comments: 0
17 hours ago
#parentprojectmusculardystrophy #sarepta ... See MoreSee Less
Sarepta Therapeutics Announces Results from Part 2 of EMBARK Study of ELEVIDYS
Sarepta Therapeutics, Inc. has announced positive topline results from Part 2 of EMBARK, the company’s Phase 3 clinical study of ELEVIDYS. ELEVIDYS is a micro-dystrophin gene therapy used for the tr...